GSK3B and early-onset autosomal dominant Alzheimer disease: Zaulkffali et al., (2019) also showed that insulin resistance in neuronal cells activates GSK3beta-mediated tau hyperphosphorylation, which is a biomarker of Alzheimer’s disease (AD).